Clinical Trials
5 trialsNCT07228247 2026-05-27
A Phase â… /â…¡a Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
Hutchmed
Phase 1/2 Recruiting
NCT05430373 2026-04-14
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Grit Biotechnology
Phase 1 Recruiting
NCT05861895 2026-04-07
HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors
HighField Biopharmaceuticals Corporation
Phase 1 Recruiting
NCT07396584 2026-03-27
HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor
Hutchmed
Phase 1/2 Recruiting
NCT07417189 2026-03-11
A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )
Abbisko Therapeutics Co, Ltd
Phase 1/2 Recruiting